chrisvoncsefalvay/vaers-outcomes huggingface dataset:
positive for COVID-19; could not taste; could not smell; This spontaneous case was reported by a nurse and describes the occurrence of AGEUSIA (could not taste), ANOSMIA (could not smell) and COVID-19 (positive for COVID-19) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included Arm fracture.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced AGEUSIA (could not taste) and ANOSMIA (could not smell). On 17-Jan-2021, the patient experienced COVID-19 (positive for COVID-19). On 19-Jan-2021, AGEUSIA (could not taste) and ANOSMIA (could not smell) had resolved. At the time of the report, COVID-19 (positive for COVID-19) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Jan-2021, SARS-CoV-2 test: positive positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medication were provided Treatment included Meloxicam for her broken arm.
Patient received second dose of Moderna vaccine although underage per guidance of DOH. Accompanied by father.
Information has been received from a consumer who saw a report on the internet about a 23 year old patient who was vaccinated with 3 doses of GARDASIL. Subsequently the patient died, the cause of the death was unknown. This is one of several reports received from the same source. Additional information has been requested.
checked blood tests about 1.5 hours after both COVID bivalent (Pfizer) and influenza quadrivalent adjuvanted (Fluad, Lot # 346372)
Fluid and feeling of pressure in ears; shakiness/trembling; dizziness; tingling/numbness in legs; sudden sharp head pain; nausea; stiff neck. Symptoms are intermittent and unpredictable in their onset. Lasts anywhere from a day to a week. Physician refused to acknowledge that the vaccine could be a potential cause of symptoms, no treatment given.  7/21/2008 MR received from PCP from 7/10/2007 (1st HPV4) through 5/01/2008. No c/o after 1st HPV4. #2 given 11/08/07.  Seen 2/28/08 with c/o recurring URI sx, neck pain, fluid in ears with occ soreness, sinus pressure, feeling tired, lightheaded, nauseous.  Assessment:  Eustachian tube dysfunction.  allergic Rhinitis. Seen again 3/17/08 with improvement in ear plugging and congestion. HPV4 #3 given.  Returned  5/01/08 with c/o L knee pain. Assessment:  Sprained medial and collateral ligaments of L knee.  Acute meniscal tear L knee.
This spontaneous report as received from a nurse refers to a multiple unspecified patients of unknown age. On an unknown date, the patients were vaccinated with an improperly stored VAQTA lot # L0122249, expiry date 05-NOV-2016. No adverse effects reported. This is one of three reports received from the same reporter. Additional information has been requested.
lot of people got problems with their eyes after receiving 2nd dose of moderna vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EYE DISORDER (lot of people got problems with their eyes after receiving 2nd dose of moderna vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EYE DISORDER (lot of people got problems with their eyes after receiving 2nd dose of moderna vaccine). At the time of the report, EYE DISORDER (lot of people got problems with their eyes after receiving 2nd dose of moderna vaccine) outcome was unknown.            This case was linked to US-MODERNATX, INC.-MOD-2021-118006 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-118006:Case for patient
Patient was tested positive of COVID-19; This spontaneous case was reported by an other caregiver and describes the occurrence of SARS-COV-2 TEST POSITIVE (Patient was tested positive of COVID-19) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Patient was tested positive of COVID-19). At the time of the report, SARS-COV-2 TEST POSITIVE (Patient was tested positive of COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Mar-2021, SARS-CoV-2 test: positive (Positive) tested positive of COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Concomitant medications not provided. Treatment information not provided.
Patient called to report that approximately 12 hours after receiving her second dose of SHINGRIX, she experienced feeling feverish (did not take a temperature to confirm), chills, and later felt sweaty and fainted. No injuries were sustained. Patient went back to bed and when she awoke, all of the symptoms were gone and she felt back to normal, no fever.
Information has been received from a physician concerning a female pediatric patient who on an unspecified date was vaccinated subcutaneously with a 0.5 mL dose of varicella virus vaccine live (Oka/Merck), and subsequently developed breakthrough varicella (previously reported as a rash) about 3 years after vaccination. Unspecified medical attention was sought. There was no product quality complaint. No further information is expected. This is one of several reports from the same source.
Cold; Headaches; This is a spontaneous report from a sponsored program. A contactable consumer (patient) reported that a male patient of unspecified age received first dose of BNT162B2 (Pfizer Covid-19 Vaccine), via an unspecified route of administration on 25Feb2021 as single dose for COVID-19 immunisation. Medical history included tested positive for covid from 08Jan2021. Concomitant medications were not reported. The patient had his first shot yesterday 25Feb2021. He tested positive for covid last 08Jan2021 and today, 26Feb2021, he had a cold, headaches, and he felt like he had Covid. Outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
40 patients administered vaccines that have undergone temperature excursion; First dose administered on 31-Jan-22 and second dose administered on 21-Mar-22; Patients administered with vaccines that have undergone temperature excursion; This spontaneous case was reported by a medical assistant and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patients administered with vaccines that have undergone temperature excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (40 patients administered vaccines that have undergone temperature excursion) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose administered on 31-Jan-22 and second dose administered on 21-Mar-22) in a 58-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 059H21A) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Jan-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 21-Mar-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 21-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients administered with vaccines that have undergone temperature excursion) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose administered on 31-Jan-22 and second dose administered on 21-Mar-22). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (40 patients administered vaccines that have undergone temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patients administered with vaccines that have undergone temperature excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (40 patients administered vaccines that have undergone temperature excursion) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose administered on 31-Jan-22 and second dose administered on 21-Mar-22) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Products were reported.  Maximum or minimum temperatures reached inside the refrigerator:- on 28-Jan-2022 temp range: positive 34.7F to positive 41.2F; on 30-Jan-2022 temp range: positive 34.7F to positive 41.2F which occurred approximately for 48 hours; on 31-Jan-2022 temp range: positive 34.7F to positive 41.2F for 12 hours and on 04-Feb-2022 temp range: positive 35.2F to positive 41.7F for 12 hours. Vials Thawed on 28-JAN-2022. Patient have reported any adverse events to date  No Treatment information was reported.
Patient vaccinated with PNEUMOVAX 23 at around 10:30 am 07/14/16. On July 15, 2016 patient returned to report reaction of redness over most of right upper arm, swelling, pain in arm. Patient reported using ice to help with pain and swelling.
Approximately 4 hours post administration the patient had a swollen tongue and throat.  He had a dry mouth and his tongue was numb.  He also had chest tightness and difficulty breathing.  The patient called the pharmacy and the RPh told him to go to the ER immediately.  He was transported via ambulance to the ER.  He claims that he was treated with an antihistamine at the hospital.  When the RPh called to follow up the next day, the patient said that his oral issues had cleared up but he still had a little chest tightness.  He claimed to feel much better.
Pt presented on 2/11/09 and had a positive urine HCG. Pt received Anthrax, Typhoid, and Small Pox. Error was identified on 3/9/09 @ 0820. Pt had follow up with Dr. and Ultrasound and GYN appointment was scheduled.
Extreme muscle weakness, inability to walk, rollover in bed, rise from a chair or bathe unassisted. Rcving. IV-gamma Globulin infusions (8) txmts. Dx with polymyositis. 60 day follow-up dated 10/16/00 states the pt is still suffering from general muscular weakness and ongoing treatment for general weakness with drugs.  Follow-up: 02/15/00 - Consent form returned by pt - sent with letter to medical center.
Vaccination Symptoms; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (Vaccination Symptoms) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccination Symptoms). At the time of the report, VACCINATION COMPLICATION (Vaccination Symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported. No treatment information was provided.  The patient reported pain Meds for Vaccination Symptoms.
Sometime within 24 hours of getting the vaccine, I lost enough vision in my right eye that by the time I was well enough to put myself together and go out, I couldn't see via my scleral contact lens anymore. I still had progressing keratoconus in my right eye at the time, but it was staged at moderate-severe. My left eye had a PKP (cornea transplant) in 2018 and was unaffected by either vaccine. I got to my optometrist within a few days who diagnosed me with corneal edema in my right eye only, which I treated with several medications. I then saw my corneal specialist within a week and the corneal edema was gone, but my cornea had thinned over 50 microns and was now in need of a transplant. I also needed a new lens as I couldn't see anything with my old one and my cornea was now rubbing on it. Nonetheless, I could only get about 20/100 VA with the new lens. I had a PKP about 8 months later on my right eye as my surgeon was pregnant at the time and then on maternity leave. She believes the rapid overnight progression of my keratoconus was likely due to the Moderna vaccine for reasons unknown at this time. I also got severely ill with both doses, but the second was worse than the first with all symptoms.  Please note I also have an IgG subclass 1 deficiency that I forget to list earlier and am on 40g of IVIG each month for that. I had been told by my immunologist that the vaccines likely wouldn't work for me, but clearly they did something.
On 3/19/99, the pt received her 1st Lymerix. 24 hours later, she experienced a paresthesia of her hand and myalgias. No treatment was given. The information received on 5/19/2000, reported the symptons resolved after 24 hours.
pt recvd vax;T 101 cranky, crying inconsolable;2 wks later became dazed uninterested; unable to sit up;could not stand; pt @ 9mo, diagnosed w/ low muscle tone;EEG showed szs;
Feeling bad; Sweating; Feels dehydrated; Not able to eat like before the vaccine; Nausea; Sore arm; Throwing up; Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling bad), HYPERHIDROSIS (Sweating), DEHYDRATION (Feels dehydrated), FEEDING DISORDER (Not able to eat like before the vaccine) and NAUSEA (Nausea) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced FEELING ABNORMAL (Feeling bad), HYPERHIDROSIS (Sweating), DEHYDRATION (Feels dehydrated), FEEDING DISORDER (Not able to eat like before the vaccine), NAUSEA (Nausea), MYALGIA (Sore arm), VOMITING (Throwing up) and HEADACHE (Slight headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 08-May-2021, MYALGIA (Sore arm) had resolved. On 09-May-2021, NAUSEA (Nausea) and VOMITING (Throwing up) had resolved. At the time of the report, FEELING ABNORMAL (Feeling bad), HYPERHIDROSIS (Sweating), DEHYDRATION (Feels dehydrated), FEEDING DISORDER (Not able to eat like before the vaccine) and HEADACHE (Slight headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitants were not provided.
had discomfort in his in his left arm; discomfort in left arm spread to chest from arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (had discomfort in his in his left arm) and CHEST DISCOMFORT (discomfort in left arm spread to chest from arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    In August 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (had discomfort in his in his left arm) and CHEST DISCOMFORT (discomfort in left arm spread to chest from arm). At the time of the report, DISCOMFORT (had discomfort in his in his left arm) and CHEST DISCOMFORT (discomfort in left arm spread to chest from arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided by the reporter. No treatment medication were provided by the reporter. No lab data provided.   Reporter did not allow further contact
MMR 1 given SC, RA , immediately developed single dime size hive alone but not a injection site. No respiratory distress. No wheeze. No further reaction. Benadryl 12.5 mg given STAT PO: pt observed x 1 hour then discharged to home.
SYMPTOMS: SWELLING IN THE LINING OF HEART, NAUSEA, CANT BREATH REALLY BAD FATIGUE FOR A WEEEK, MASSIVE HEADACHE.  CURRENTLY TAKING ANTI ANFLAMMATORY FOR PAIN AND SWELLING. PATIENT DIAGNOSED WITH PERICARDITIS AND COSTOCHONDRITIS
initial; swelling of tongue, tingling and numbness in legs, syncope. later; HA
the pharmacist asked if patient had any side effects after first dose of vaccine.  patient stated fever and flu like symptoms. After I injected the vaccine, patient stated he had blurry vision after the first dose of vaccine and still has blurry vision. Since he told me this side effect after the vaccine administration, I instructed him to tell his doctor as soon as possible. He said he can only see his doctor later July for an appointment. I told him to call his doctor and talk to him over the phone about the side effect and treatment options in addition to seeing the doctor as soon as possible for the soonest available appointment.
Patient came to outreach vaccination clinic and received 3rd dose of Pfizer vaccine. No adverse outcome noted.
Patient stated they experienced a large red, warm, itchy rash on the right arm two weeks after vaccination. Nothing was used to treat the rash. Patient stated a few days later the rash went away.
Patient stated they were having nausea that was not going away with otc medications. They called their md who told them to call us.  Patient stated that the nausea started 10 days after the shot and was really bad sometime. We informed them to call their md back to see if they could get a script for zofran to help with the severe nausea.
I had my vaccine at 0910 and was instructed to wait 15 minutes post-injection to monitor for any reaction. While seated, at 0920 I felt suddenly extremely lightheaded, dizzy, and nauseous. I had a feeling in my chest like my heart was racing and I check my HR on my watch and it read 120-125 bpm. My baseline HR is 60-70 at rest. I notified staff immediately and was placed onto a stretcher. The rapid response team was called and I was brought to the emergency department on site for evaluation. In my recollection, my heart rate came down to the 70?s/80?s within the hour at which time the feeling like my heart was racing had subsided. The nausea was treated with 4mg IV Zofran. My lightheadedness, dizziness, and nausea resolved with a 1,000 mL NS Bolus. I was discharged home at approximately 1145 with a mild to moderate headache and generalized fatigue.
Tingling sensation all extremities. Hand and forearm cramps in left arm (injection site) now affecting left leg (calf) Left side of face has spasms and numbness.
She experienced soreness on her arm after the first shot, this morning she had more soreness after the second shot; This is a spontaneous report received from a contactable reporter (Consumer) from medical information team. The reporter is the patient.  An 85-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: bnt162b2 (Dose 1, single (Lot Number: Not provided)), for COVID-19 Immunization, reaction: "She experienced soreness on her arm". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "She experienced soreness on her arm after the first shot, this morning she had more soreness after the second shot".  Additional Information: The patient was asking if it was true that the Pfizer's vaccine lasts up to six months.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021289238 Same patient and drug; Different  dose and events
Dull back ache leading to pain and numbness in left leg, pelvis and buttocks.  MRI revealed transverse myelitis.  Hospitalized almost continuously over 3-week period. Treated with oral steroids. Then IV steroids.  Then oral steroids again.
Pt vaccinated with HIB Titer developed vomiting X1, decreased appetite, irritable.
After getting dose 3 I had a hard time catching my breathe and I couldn't breathe. It lasted for about a week. Had the body aches, headache, fatigue. Went to the doctor and took breathing treatment for 5-6 days.
Patient died suddenly while snowblowing.    12/18/07 Reporter states no autopsy done.  Received vax record which confirms lot # as reported.  2/29/08 Received death certificate which states COD as cardiac arrest w/CAD as contributing factor.
Janssen COVID-19 Vaccine Dizziness and nausea immediately after receiving shot.  Headache, body aches, fever and chills approx. 6 hours after injection.
We stock the pediatric hepatitis B vaccine (Engerix B) 10 mcg dose/syringe from GlaxoSmithKline.  We used to receive the individual syringes labeled as "For Pediatric and Adolescents Only".  Now, the manufacturer has changed the labeling such that this comment is no longer printed on each syringe.  It is, however, still printed on the outer box.  More often than not, the box (with "For Pediatric and Adolescents") may be discarded and we have no way of knowing what it is except for the color and the dose on the syringe.  Adult dose syringes are also with the same problem of no comment as "adult only" printed on the label of the syringe.  This is clearly an area of labeling to be improved on, as the adult syringe can be very easily mistaken with the adult syringe (same size syringe, just different dose and strength) and vice versa.
Abscessed tooth; This spontaneous case was reported by a consumer and describes the occurrence of TOOTH ABSCESS (Abscessed tooth) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TOOTH ABSCESS (Abscessed tooth). At the time of the report, TOOTH ABSCESS (Abscessed tooth) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medications are provided. treatment to the events not reported. patient will not get her second injection.
Sore arm: immediately and for 2 succeeding days. Fatigue, aching, headache, general malaise, nausea: onset on day 2; abated by day 3.
PT WAS ADMINISTERED EXPIRED VACCINE. MODERNA EXPIRED  ON 10/11/21. IT WAS ADMINISTERED ON 10/13/21.